SIRT3 and gestational diabetes: Moreover, the resistance observed in cases of SIRT3 deficiency to autophagy-dependent ferroptosis induced by high glucose and erastin implies that targeting SIRT3 might hold promise as a therapeutic approach for the treatment of gestational diabetes mellitus (GDM) [16].